JCR Pharmaceuticals Co (TSE:4552) Cyclically Adjusted Book per Share: 円353.36 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4552 JCR Pharmaceuticals Co Ltd TSE:4552
42 GF Score
Price 円522.00
GF Value 円770.84
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is JCR Pharmaceuticals Co Cyclically Adjusted Book per Share?

JCR Pharmaceuticals Co TSE:4552 -0.38% 42 Cyclically Adjusted Book per Share is 円353.36 as of Mar. 2026. GuruFocus rates TSE:4552 with a GF Score™ of 42/100 and a GF Value™ of 円770.84 (Possible Value Trap). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

JCR Pharmaceuticals Co's adjusted book value per share for the three months ended in Mar. 2026 was 円384.760. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円353.36 for the trailing ten years ended in Mar. 2026.

During the past 12 months, JCR Pharmaceuticals Co's average Cyclically Adjusted Book Growth Rate was 5.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of JCR Pharmaceuticals Co was 11.40% per year. The lowest was 4.20% per year. And the median was 8.90% per year.

As of today (2026-07-16), JCR Pharmaceuticals Co's current stock price is 円522.00. JCR Pharmaceuticals Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was 円353.36. JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio of today is 1.48.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of JCR Pharmaceuticals Co was 17.23. The lowest was 1.26. And the median was 7.04.


JCR Pharmaceuticals Co  (TSE:4552) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=522.00/353.36
=1.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of JCR Pharmaceuticals Co was 17.23. The lowest was 1.26. And the median was 7.04.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


JCR Pharmaceuticals Co Cyclically Adjusted Book per Share Related Terms


JCR Pharmaceuticals Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for JCR Pharmaceuticals Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JCR Pharmaceuticals Co Cyclically Adjusted Book per Share Chart

JCR Pharmaceuticals Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 241.97 271.75 302.33 334.20 353.36

JCR Pharmaceuticals Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 334.20 339.62 344.38 350.79 353.36

TSE:4552 vs LLY, JNJ, ABBV: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JCR Pharmaceuticals Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio falls into.


TSE:4552
42GF Score
JCR Pharmaceuticals Co Ltd TSE:4552
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JCR Pharmaceuticals Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, JCR Pharmaceuticals Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=384.76/112.7000*112.7000
=384.760

Current CPI (Mar. 2026) = 112.7000.

JCR Pharmaceuticals Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 207.711 98.100 238.624
201609 211.200 98.000 242.880
201612 213.295 98.400 244.292
201703 218.363 98.100 250.861
201706 219.361 98.500 250.985
201709 215.645 98.800 245.984
201712 218.313 99.400 247.524
201803 222.251 99.200 252.497
201806 221.617 99.200 251.777
201809 231.631 99.900 261.309
201812 233.046 99.700 263.433
201903 249.048 99.700 281.522
201906 246.824 99.800 278.728
201909 252.344 100.100 284.108
201912 256.410 100.500 287.536
202003 262.648 100.300 295.119
202006 264.903 99.900 298.845
202009 269.874 99.900 304.452
202012 281.478 99.300 319.462
202103 310.472 99.900 350.252
202106 314.849 99.500 356.618
202109 378.716 100.100 426.387
202112 398.495 100.100 448.655
202203 411.136 101.100 458.309
202206 410.142 101.800 454.057
202209 409.019 103.100 447.104
202212 420.453 104.100 455.188
202303 418.037 104.400 451.272
202306 422.421 105.200 452.537
202309 455.632 106.200 483.519
202312 445.926 106.800 470.560
202403 450.114 107.200 473.208
202406 443.445 108.200 461.888
202409 451.820 108.900 467.586
202412 431.545 110.700 439.342
202503 388.550 111.100 394.146
202506 379.648 111.700 383.047
202509 394.757 112.000 397.224
202512 379.738 113.000 378.730
202603 384.760 112.700 384.760

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of 円353.36 mean?
JCR Pharmaceuticals Co (TSE:4552) has a Cyclically Adjusted Book per Share of 円353.36 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on JCR Pharmaceuticals Co and its competitors.
Is JCR Pharmaceuticals Co's Cyclically Adjusted Book per Share too high?
JCR Pharmaceuticals Co's current Cyclically Adjusted Book per Share is 円353.36. Overall, JCR Pharmaceuticals Co has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JCR Pharmaceuticals Co's Cyclically Adjusted Book per Share compare to LLY and JNJ?
JCR Pharmaceuticals Co's Cyclically Adjusted Book per Share of 円353.36 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on JCR Pharmaceuticals Co and its competitors. JCR Pharmaceuticals Co's current Cyclically Adjusted Book per Share is 円353.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JCR Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co (TSE:4552) is currently considered Possible Value Trap. The stock's GF Value™ is 円770.84, compared to a current price of 円522.00 — trading 32.3% below its estimated fair value. The current Cyclically Adjusted Book per Share is 円353.36. JCR Pharmaceuticals Co's overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For JCR Pharmaceuticals Co (TSE:4552), the current Cyclically Adjusted Book per Share is 円353.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JCR Pharmaceuticals Co (TSE:4552) Overvalued in 2026?

Based on GuruFocus' analysis, JCR Pharmaceuticals Co stock appears to be undervalued. The current stock price of 円522.00 is trading 32.3% below its estimated GF Value™ of 円770.84. GuruFocus considers JCR Pharmaceuticals Co to be Possible Value Trap.

Key valuation signals for TSE:4552:

  • Cyclically Adjusted Book per Share: 円353.36
  • GF Value™: 円770.84 vs. price of 円522.00 (32.3% below fair value)
  • GF Score™: 42/100 with 7 warning signs

No single metric tells the full story. See the TSE:4552 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


JCR Pharmaceuticals Co Business Description

Other Exchanges JCRRF:USA
Address 3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.
42GF Score

Get the complete analysis for TSE:4552

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円522.00
Price
円770.84
GF Value